Marie-Hélène Antoine Selected Research

Fibrosis (Cirrhosis)

10/2022	Protective Effect of Nebivolol against Oxidative Stress Induced by Aristolochic Acids in Endothelial Cells.
6/2020	Characterization of cytotoxic effects of aristolochic acids on the vascular endothelium.
1/2018	CD4+ and CD8+ T Cells Exert Regulatory Properties During Experimental Acute Aristolochic Acid Nephropathy.
1/2016	Blocking TGF-β Signaling Pathway Preserves Mitochondrial Proteostasis and Reduces Early Activation of PDGFRβ+ Pericytes in Aristolochic Acid Induced Acute Kidney Injury in Wistar Male Rats.
1/2016	New in vitro insights on a cell death pathway induced by magnolol and honokiol in aristolochic acid tubulotoxicity.
12/2015	Human bone morphogenetic protein-7 does not counteract aristolochic acid-induced renal toxicity.
5/2015	Substitution between Aristolochia and Bryonia genus in North-Eastern Morocco: toxicological implications.
4/2015	Nephroprotective effects of ferulic acid, Z-ligustilide and E-ligustilide isolated from Angelica sinensis against cisplatin toxicity in vitro.
11/2012	Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marie-Hélène Antoine Research Topics

Disease

9	Fibrosis (Cirrhosis) 10/2022 - 11/2012
6	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 11/2012
4	Atrophy 06/2020 - 11/2012
3	Neoplasms (Cancer) 11/2019 - 12/2014
3	Necrosis 01/2018 - 11/2012
2	Chronic Renal Insufficiency 10/2017 - 12/2015
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2022
1	Hypoxia (Hypoxemia) 06/2020
1	Glycosuria 11/2019
1	Sepsis (Septicemia) 10/2017
1	Dehydration (Water Stress) 10/2017
1	Infections 11/2016
1	Cicatrix (Scar) 01/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2016
1	Urologic Neoplasms (Urological Cancer) 05/2015
1	Wounds and Injuries (Trauma) 11/2012
1	Edema (Dropsy) 11/2012
1	Hyperinsulinism (Hyperinsulinemia) 11/2002
1	Insulinoma 11/2002

Drug/Important Bio-Agent (IBA)

7	aristolochic acid I (aristolochic acid)IBA 01/2022 - 11/2012
6	Aristolochic AcidsIBA 10/2022 - 05/2015
4	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 12/2014
2	CollagenIBA 12/2015 - 04/2015
2	Pharmaceutical PreparationsIBA 07/2015 - 04/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2019
1	Contrast MediaIBA 10/2017
1	DiureticsIBA 10/2017
1	trichostatin A (A 300)IBA 11/2016
1	theasinensin AIBA 11/2016
1	LignansIBA 01/2016
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2016
1	Annexin A5IBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	Bone Morphogenetic Protein 7IBA 12/2015
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 12/2015
1	CateninsIBA 04/2015
1	Alkylating AgentsIBA 12/2014
1	Probenecid (Benemid)FDA LinkGeneric 11/2012
1	CreatinineIBA 11/2012
1	Diazoxide (Hyperstat)FDA Link 11/2002
1	Potassium Channels (Potassium Channel)IBA 11/2002
1	Adenosine (Adenocard)FDA LinkGeneric 11/2002
1	BPDZ 154IBA 11/2002
1	Adenosine Triphosphate (ATP)IBA 11/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 10/2017
1	Transplantation 01/2016